Xeris Biopharma will present new and updated data on ready-to-use glucagon, Cushing’s syndrome treatment and a once-weekly levothyroxine candidate at three US medical meetings this autumn. Xeris Biopharma Holdings said it will present new and updated data on three of…
Evidence from Europe and the United States shows that type 2 diabetes varies sharply by income, ethnicity and geography, challenging prevention strategies centred solely on individual lifestyle choices. A commentary on the redGDPS blog says the pattern of type 2…
A study of 107 adults in South Sumatra found that confidence in managing type 2 diabetes was associated with less emotional strain, while perceived support from family and friends was not. In a study of adults with type 2 diabetes…
A study of 107 adults in South Sumatra found that confidence in managing daily diabetes tasks was associated with lower emotional strain, while general social support was not. In adults with type 2 diabetes, the emotional strain of daily disease…
Doctors say GLP-1 medicines can transform care for some people with obesity, but warn against cosmetic use, unapproved products and abandoning long-term lifestyle support. GLP-1 medicines, once best known for helping people with type 2 diabetes control blood sugar, have…
Doctors say GLP-1 therapies can transform health for some patients, but warn that rising demand for rapid cosmetic weight loss risks misuse and weakens clinical safeguards. GLP-1 medicines have moved from diabetes clinics into the centre of a wider debate…
Standard buttered toast is low in fibre and can be less filling than wholegrain alternatives, while heavily browned slices and mouldy bread raise separate food-safety concerns. Toast may be a breakfast staple in many homes because it is cheap, convenient…
A Rutgers study found three to four additional cases of ischaemic optic neuropathy per 10,000 patients taking GLP-1 medicines over 18 months, but researchers say the association does not prove the drugs are the cause. Researchers at Rutgers University have…
Higher consumption of Neu5Gc, a molecule found mainly in beef and lamb, was associated with a greater risk of type 2 diabetes among 89,953 French adults, although the observational study cannot prove cause and effect. Researchers analysing data from France’s…
Analysis of nearly 88,000 older adults with fatty liver disease found lower rates of liver decompensation, hospitalisation and death among GLP-1 users, but higher risks of osteoporosis and retinopathy. A class of diabetes and weight-loss medicines built around GLP-1 receptor…
